ATORVASTATIN CALCIUM

Product NDC: 60760-883
11-digit product format: 607600883
Labeler code: 60760
Product ID: 60760-883_557a1213-9c49-7aa2-e063-6294a90a7528
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: ATORVASTATIN CALCIUM
Dosage form: TABLET, FILM COATED
Route: ORAL
Labeler: St. Mary's Medical Park Pharmacy
Application: ANDA214344
Marketing category: ANDA
Marketing start: 2025-02-28
Substance: ATORVASTATIN CALCIUM TRIHYDRATE
Active strength: 20 mg/1
Pharmacologic classes: HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]
NDC exclude flag: No
Listing certified through: 2027-12-31
Current FDA listing: Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 4 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	Approval date
A214344-001	ATORVASTATIN CALCIUM	ATORVASTATIN CALCIUM	EQ 10MG BASE	TABLET / ORAL	AB	2023-09-12
A214344-002	ATORVASTATIN CALCIUM	ATORVASTATIN CALCIUM	EQ 20MG BASE	TABLET / ORAL	AB	2023-09-12
A214344-003	ATORVASTATIN CALCIUM	ATORVASTATIN CALCIUM	EQ 40MG BASE	TABLET / ORAL	AB	2023-09-12
A214344-004	ATORVASTATIN CALCIUM	ATORVASTATIN CALCIUM	EQ 80MG BASE	TABLET / ORAL	AB	2023-09-12

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 4 matching rows.

Application-product, TE code table
Application-product	TE code
A214344-001	AB
A214344-002	AB
A214344-003	AB
A214344-004	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 88 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-09-14 22:38:34	2026-08	A214344-001	ATORVASTATIN CALCIUM	EQ 10MG BASE	TABLET / ORAL	AB	2023-09-12	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A214344-002	ATORVASTATIN CALCIUM	EQ 20MG BASE	TABLET / ORAL	AB	2023-09-12	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A214344-003	ATORVASTATIN CALCIUM	EQ 40MG BASE	TABLET / ORAL	AB	2023-09-12	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A214344-004	ATORVASTATIN CALCIUM	EQ 80MG BASE	TABLET / ORAL	AB	2023-09-12	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	A214344-001	ATORVASTATIN CALCIUM	EQ 10MG BASE	TABLET / ORAL	AB	2023-09-12	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A214344-002	ATORVASTATIN CALCIUM	EQ 20MG BASE	TABLET / ORAL	AB	2023-09-12	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A214344-003	ATORVASTATIN CALCIUM	EQ 40MG BASE	TABLET / ORAL	AB	2023-09-12	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A214344-004	ATORVASTATIN CALCIUM	EQ 80MG BASE	TABLET / ORAL	AB	2023-09-12	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A214344-001	ATORVASTATIN CALCIUM	EQ 10MG BASE	TABLET / ORAL	AB	2023-09-12	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A214344-002	ATORVASTATIN CALCIUM	EQ 20MG BASE	TABLET / ORAL	AB	2023-09-12	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A214344-003	ATORVASTATIN CALCIUM	EQ 40MG BASE	TABLET / ORAL	AB	2023-09-12	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A214344-004	ATORVASTATIN CALCIUM	EQ 80MG BASE	TABLET / ORAL	AB	2023-09-12	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A214344-001	ATORVASTATIN CALCIUM	EQ 10MG BASE	TABLET / ORAL	AB	2023-09-12	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A214344-002	ATORVASTATIN CALCIUM	EQ 20MG BASE	TABLET / ORAL	AB	2023-09-12	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A214344-003	ATORVASTATIN CALCIUM	EQ 40MG BASE	TABLET / ORAL	AB	2023-09-12	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A214344-004	ATORVASTATIN CALCIUM	EQ 80MG BASE	TABLET / ORAL	AB	2023-09-12	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A214344-001	ATORVASTATIN CALCIUM	EQ 10MG BASE	TABLET / ORAL	AB	2023-09-12	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A214344-002	ATORVASTATIN CALCIUM	EQ 20MG BASE	TABLET / ORAL	AB	2023-09-12	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A214344-003	ATORVASTATIN CALCIUM	EQ 40MG BASE	TABLET / ORAL	AB	2023-09-12	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A214344-004	ATORVASTATIN CALCIUM	EQ 80MG BASE	TABLET / ORAL	AB	2023-09-12	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A214344-001	ATORVASTATIN CALCIUM	EQ 10MG BASE	TABLET / ORAL	AB	2023-09-12	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A214344-002	ATORVASTATIN CALCIUM	EQ 20MG BASE	TABLET / ORAL	AB	2023-09-12	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A214344-003	ATORVASTATIN CALCIUM	EQ 40MG BASE	TABLET / ORAL	AB	2023-09-12	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A214344-004	ATORVASTATIN CALCIUM	EQ 80MG BASE	TABLET / ORAL	AB	2023-09-12	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A214344-001	ATORVASTATIN CALCIUM	EQ 10MG BASE	TABLET / ORAL	AB	2023-09-12	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A214344-002	ATORVASTATIN CALCIUM	EQ 20MG BASE	TABLET / ORAL	AB	2023-09-12	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A214344-003	ATORVASTATIN CALCIUM	EQ 40MG BASE	TABLET / ORAL	AB	2023-09-12	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A214344-004	ATORVASTATIN CALCIUM	EQ 80MG BASE	TABLET / ORAL	AB	2023-09-12	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A214344-001	ATORVASTATIN CALCIUM	EQ 10MG BASE	TABLET / ORAL	AB	2023-09-12	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A214344-002	ATORVASTATIN CALCIUM	EQ 20MG BASE	TABLET / ORAL	AB	2023-09-12	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A214344-003	ATORVASTATIN CALCIUM	EQ 40MG BASE	TABLET / ORAL	AB	2023-09-12	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A214344-004	ATORVASTATIN CALCIUM	EQ 80MG BASE	TABLET / ORAL	AB	2023-09-12	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A214344-001	ATORVASTATIN CALCIUM	EQ 10MG BASE	TABLET / ORAL	AB	2023-09-12	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A214344-002	ATORVASTATIN CALCIUM	EQ 20MG BASE	TABLET / ORAL	AB	2023-09-12	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A214344-003	ATORVASTATIN CALCIUM	EQ 40MG BASE	TABLET / ORAL	AB	2023-09-12	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A214344-004	ATORVASTATIN CALCIUM	EQ 80MG BASE	TABLET / ORAL	AB	2023-09-12	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A214344-001	ATORVASTATIN CALCIUM	EQ 10MG BASE	TABLET / ORAL	AB	2023-09-12	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A214344-002	ATORVASTATIN CALCIUM	EQ 20MG BASE	TABLET / ORAL	AB	2023-09-12	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A214344-003	ATORVASTATIN CALCIUM	EQ 40MG BASE	TABLET / ORAL	AB	2023-09-12	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A214344-004	ATORVASTATIN CALCIUM	EQ 80MG BASE	TABLET / ORAL	AB	2023-09-12	`5bbf6a4d5a75…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 3 · 88 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-09-14 22:38:34	2026-08	A214344-001	AB	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A214344-002	AB	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A214344-003	AB	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A214344-004	AB	1	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	A214344-001	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A214344-002	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A214344-003	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A214344-004	AB	1	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A214344-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A214344-002	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A214344-003	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A214344-004	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A214344-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A214344-002	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A214344-003	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A214344-004	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A214344-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A214344-002	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A214344-003	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A214344-004	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A214344-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A214344-002	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A214344-003	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A214344-004	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A214344-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A214344-002	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A214344-003	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A214344-004	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A214344-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A214344-002	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A214344-003	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A214344-004	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A214344-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A214344-002	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A214344-003	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A214344-004	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A214344-001	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A214344-002	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A214344-003	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A214344-004	AB	1	`5bbf6a4d5a75…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product: Yes
Brand name base: ATORVASTATIN CALCIUM
Listing expiration: 2027-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
ATORVASTATIN CALCIUM TRIHYDRATE	20 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
48A5M73Z4Q	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
617310	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
2f76cd3b-fbfa-a193-e063-6294a90a1b32	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
fa898d56-9495-d6f0-309b-68a5d8e3914a	Product name	4	20260305
d25cba4b-d79e-4890-8837-1382f7d09489	Product name	1	20231002
91774e91-b249-45e3-8ff8-4b5db2927a69	Product name	1	20230718
03fb3cda-d60a-4873-94e9-6fa77cfb1a1c	Product name	1	20220302
34152997-af0b-acf4-dcaf-37211afe8ca4	Product name	9	20210312
46fdf265-6d5a-1bfb-93db-d82a4ea8aa81	Product name	1	20140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
60760-883-90	ATORVASTATIN CALCIUM	90 in 1 BOTTLE, PLASTIC	TABLET, FILM COATED	90		1

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
60760-883-90	EA - Each	60760-883	1f8d44b4-f053-46ea-8bab-7d5d30204314	1	2025-05-14

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
60760-883	ATORVASTATIN CALCIUM TABLET, FILM COATED [ST. MARY'S MEDICAL PARK PHARMACY]	1	Current NDC, 1 package rows	20250305_2f76cd3b-fbfa-a193-e063-6294a90a1b32.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 2 of 2 · 35 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
ATORVASTATIN CALCIUM	ATORVASTATIN CALCIUM	A-S Medication Solutions	510426cd-63fa-4ead-81d9-0b2f4e3c1052	2025-04-10	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 214344 application number: ANDA214344
ATORVASTATIN CALCIUM	ATORVASTATIN CALCIUM	A-S Medication Solutions	9fb1a276-8253-49f0-930e-6e158d643500	2025-04-09	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 214344 application number: ANDA214344
ATORVASTATIN CALCIUM	ATORVASTATIN CALCIUM	A-S Medication Solutions	fff3e5db-d15f-4eb0-b9ed-7961b4e078e4	2025-04-09	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 214344 application number: ANDA214344
ATORVASTATIN CALCIUM	ATORVASTATIN CALCIUM	Coupler LLC	2f2152b6-790c-aa4a-e063-6294a90a3b18	2025-02-27	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 214344 application number: ANDA214344
ATORVASTATIN CALCIUM	ATORVASTATIN CALCIUM	Coupler LLC	2de6b9b3-8f3c-599e-e063-6394a90aee60	2025-02-11	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 214344 application number: ANDA214344
ATORVASTATIN CALCIUM	ATORVASTATIN CALCIUM	Bryant Ranch Prepack	49e0e9e7-447d-4d9d-847e-46d68a77db2d	2025-01-21	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 214344 application number: ANDA214344
Atorvastatin Calcium	ATORVASTATIN CALCIUM	Direct_Rx	23ac06e0-556c-c640-e063-6394a90a931d	2025-01-14	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 214344 application number: ANDA214344
ATORVASTATIN CALCIUM	ATORVASTATIN CALCIUM	Proficient Rx LP	4b2d0de1-50f0-4356-aa79-88696be8ac3d	2024-11-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 214344 application number: ANDA214344
ATORVASTATIN CALCIUM	ATORVASTATIN CALCIUM	Bryant Ranch Prepack	76e8e69c-590f-4f74-82e1-199d8d14fa80	2024-11-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 214344 application number: ANDA214344
ATORVASTATIN CALCIUM	ATORVASTATIN CALCIUM	Proficient Rx LP	5a132b72-5318-43ab-881d-a2e51bd20bdc	2024-11-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 214344 application number: ANDA214344
ATORVASTATIN CALCIUM	ATORVASTATIN CALCIUM	A-S Medication Solutions	57b070d1-217a-413b-9350-e2387c5c282a	2024-10-23	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 214344 application number: ANDA214344
ATORVASTATIN CALCIUM	ATORVASTATIN CALCIUM	A-S Medication Solutions	9d11f845-8e56-4251-8a1f-8f4b3843ea62	2024-10-23	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 214344 application number: ANDA214344
ATORVASTATIN CALCIUM	ATORVASTATIN CALCIUM	NuCare Pharmaceuticals, Inc.	251828ae-7519-35c2-e063-6394a90a71ea	2024-10-22	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 214344 application number: ANDA214344
ATORVASTATIN CALCIUM	ATORVASTATIN CALCIUM	NorthStar RxLLC	c1ba8fd9-aa40-466c-81bd-a87b364e9a1a	2024-09-27	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 214344 application number: ANDA214344
ATORVASTATIN CALCIUM	ATORVASTATIN CALCIUM	NuCare Pharmaceuticals,Inc,	1adc3c12-1a78-33a0-e063-6294a90a486a	2024-06-14	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 214344 application number: ANDA214344

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
48A5M73Z4Q	ATORVASTATIN CALCIUM TRIHYDRATE	344423-98-9	ATORVASTATIN CALCIUM TRIHYDRATE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
617310	atorvastatin calcium 20 MG Oral Tablet	PSN	2f76cd3b-fbfa-a193-e063-6294a90a1b32	1
617310	atorvastatin 20 MG Oral Tablet	SCD	2f76cd3b-fbfa-a193-e063-6294a90a1b32	1
617310	atorvastatin (as atorvastatin calcium) 20 MG Oral Tablet	SY	2f76cd3b-fbfa-a193-e063-6294a90a1b32	1

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Sample	Exclude flag	Status
60760-883-90	60760088390	90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (60760-883-90)	2025-02-28	No	No	Current